{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:22:15Z","timestamp":1787775735840,"version":"build-2784847793"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>Bullous pemphigoid (BP) is an autoimmune blistering disorder rarely triggered by antituberculous therapy (ATT). A 56-year-old diabetic female developed extensive fluid-filled blisters 72 h after initiating first-line ATT. Skin biopsy and immunofluorescence confirmed BP. ATT was stopped, and treatment with systemic and topical steroids resulted in clinical improvement. Although ATT is known for a wide range of adverse effects, BP is an extremely rare but serious dermatologic toxicity. Early identification and withdrawal of the offending drug are crucial.<\/jats:p>","DOI":"10.4103\/jpbs.jpbs_922_25","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:12Z","timestamp":1763683212000},"page":"S260-S262","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Antituberculous Therapy-Induced Rare Skin Toxicity: Bullous Pemphigoid"],"prefix":"10.4103","volume":"18","author":[{"given":"Reshma C.","family":"Patil","sequence":"first","affiliation":[{"name":"Department of General Medicine, M. S. Ramaiah Medical College Hospital, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwanath","family":"Krishnamurthy","sequence":"additional","affiliation":[{"name":"Department of General Medicine, M. S. Ramaiah Medical College Hospital, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Prabhu","sequence":"additional","affiliation":[{"name":"Department of General Medicine, M. S. Ramaiah Medical College Hospital, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Praveen","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, M. S. Ramaiah Medical College Hospital, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"R1-20260310","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jaad.2020.05.045","article-title":"Management of immune checkpoint inhibitor-induced bullous pemphigoid","volume":"84","author":"Apalla","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R2-20260310","doi-asserted-by":"crossref","first-page":"e15623","DOI":"10.1111\/dth.15623","article-title":"Dupilumab for the treatment of pembrolizumab-induced bullous pemphigoid: A case report","volume":"35","author":"Pop","year":"2022","journal-title":"Dermatol Ther"},{"key":"R3-20260310","first-page":"37","article-title":"Bullous pemphigoid due to isoniazid","volume":"9","author":"Madegedara","year":"2020","journal-title":"Int J Case Stud"},{"key":"R4-20260310","doi-asserted-by":"crossref","first-page":"e15330","DOI":"10.1111\/dth.15330","article-title":"A successful case of vesicular pemphigoid concurrent with pulmonary tuberculosis with dupilumab","volume":"35","author":"Shan","year":"2022","journal-title":"Dermatol Ther"},{"key":"R5-20260310","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1111\/1346-8138.15770","article-title":"Case of bullous pemphigoid under treatment with adalimumab for hidradenitis suppurativa","volume":"48","author":"Sugaya","year":"2021","journal-title":"J Dermatol"},{"key":"R6-20260310","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1111\/1346-8138.15756","article-title":"PD-L1 positive macrophages were increased in a case of pembrolizumab-induced bullous pemphigoid","volume":"48","author":"Nakai","year":"2021","journal-title":"J Dermatol"},{"key":"R7-20260310","doi-asserted-by":"crossref","first-page":"e15466","DOI":"10.1111\/dth.15466","article-title":"Self-resolving bullous pemphigoid induced by cemiplimab","volume":"35","author":"Molle","year":"2022","journal-title":"Dermatol Ther"},{"key":"R8-20260310","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/bjd.19313","article-title":"Diagnostic and therapeutic differences between immune checkpoint inhibitor-induced and idiopathic bullous pemphigoid: A cross-sectional study","volume":"183","author":"Molina","year":"2020","journal-title":"Br J Dermatol"},{"key":"R9-20260310","doi-asserted-by":"crossref","first-page":"e13970","DOI":"10.1111\/dth.13970","article-title":"Nivolumab-associated pemphigoid-like blistering dermatosis after sun exposure","volume":"33","author":"Kluger","year":"2020","journal-title":"Dermatol Ther"},{"key":"R10-20260310","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/1346-8138.16534","article-title":"Bullous pemphigoid during the treatment of psoriasis vulgaris with risankizumab","volume":"50","author":"Fukada","year":"2023","journal-title":"J Dermatol"}],"container-title":["Journal of Pharmacy and Bioallied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_922_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:40:57Z","timestamp":1787773257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_922_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":10,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_922_25","relation":{},"ISSN":["0976-4879","0975-7406"],"issn-type":[{"value":"0976-4879","type":"print"},{"value":"0975-7406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"2025-05-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}